Evolent Health (EVH) Treasury Shares (2014 - 2026)

Evolent Health has reported Treasury Shares for 7 years, with the latest figure at $61.4 million in Q2 2026.

• On a quarterly basis, Treasury Shares rose 190.82% year-over-year to $61.4 million in Q2 2026; TTM through Jun 2026 was $61.4 million, a 190.82% increase from a year earlier, with the FY2025 full-year figure at $61.4 million, up 190.82% from the prior year.
• Treasury Shares was $61.4 million for Q2 2026 at Evolent Health, roughly flat from $61.4 million in the prior quarter.
• The five-year high for Treasury Shares was $6.0 million in Q3 2025, with the low at $1.5 million in Q1 2022.
• Average Treasury Shares over 5 years is $2.5 million, with a median of $1.5 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares changed 0.0% in 2022, then soared 190.83% in 2025.
• Over 5 years, Treasury Shares stood at $21.1 million in 2022, then changed by 0.0% to $21.1 million in 2023, then changed by 0.0% to $21.1 million in 2024, then jumped by 190.82% to $61.4 million in 2025, then changed by 0.0% to $61.4 million in 2026.
• The last three Treasury Shares figures came in at $61.4 million (Q2 2026), $61.4 million (Q1 2026), and $61.4 million (Q4 2025), per Business Quant data.